best time to take oral glp 1 Day Start GLP-1: Timing Your First Dose – Cured Pharmacy What To Expect When Starting
Description
The SURMOUNT-1 trial (tirzepatide, published in NEJM 2022) demonstrated that participants with obesity or overweight without diabetes who received tirzepatide experienced weight reductions of 16.0% (5mg), 21.4% (10mg), and 22.5% (15mg) over 72 weeks
Rohit Kohli, Email: [email protected]
On April 1, 2026, the FDA approved Eli Lillys FOUNDAYO (orforglipron) , the second oral GLP-1 approved for obesity, and arguably the one with the more patient-friendly convenience profile
Similar packaging, similar dosing schedules, or changes in dose can create confusion
They test their levels, identify specific deficiencies, source targeted supplements at therapeutic doses, and adjust based on results
